
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW SHARES OF GELION PLC.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 AS IT FORMS PART OF
UNLESS OTHERWISE DEFINED, CAPITALISED TERMS USED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT PUBLISHED AT APPRXOMATELY
("Gelion" or the "Company")
Result of Placing and Subscription
and
Posting of Circular and Notice of General Meeting
The Placing raised gross proceeds of
As part of the Fundraising, the Company also announced details of a Retail Offer to be made to existing Shareholders and new
Posting of Circular and Notice of General Meeting
The Placing, Subscription and Retail Offer are each conditional, inter alia, upon Shareholders approving the Resolutions at the General Meeting which is expected to be held on
Directors' Participation
Details of the Directors' participation in the Fundraising is set out as follows:
Director |
Number of Existing Ordinary Shares |
Number of New Shares subscribed for |
Total number of Ordinary Shares held on Admission |
Percentage of Enlarged Share Capital on Admission* |
Prof. |
17,874,003 |
50,000 |
17,924,003 |
7.82% |
Dr |
3,103,893 |
125,000 |
3,228,893 |
1.41% |
Dr |
2,550,000 |
625,000 |
3,175,000 |
1.38% |
|
1,495,577 |
125,000 |
1,620,577 |
0.71% |
|
784,110 |
125,000 |
909,110 |
0.40% |
|
514,571 |
75,000 |
589,571 |
0.26% |
*Assuming the Retail Offer is subscribed in full.
Related Party Transaction
The above Directors' participation in the Fundraising constitutes a related party transaction pursuant to Rule 13 of the AIM Rules by virtue of their status as Directors of the Company. The independent director of the Company for the purposes of the Fundraise,
Admission
Application will be made for the New Shares to be issued pursuant to the Fundraising to be admitted to trading on AIM, which is expected to take place at
CONTACTS
Prof. |
via Alma |
|
+44 (0) 20 7409 3494 |
|
+44 (0) 20 3179 5300 |
|
+44 (0) 203 002 2073 |
|
+44 (0) 20 3405 0205 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the